Skip to main content

Table 3 Univariate analysis of pre and post initial TACE serum AFP levels and association with overall survival

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Variable

n

%

Hazard Ratio

Lower 95% CI

Higher 95% CI

P value

Baseline AFP ≥ 200 ng/ml

260

23%

1.48

1.07

2.04

0.015

Post initial TACE AFP ≥ 200 ng/ml

177

17%

2.19

1.43

3.36

<0.001

Baseline AFP ≥ 400 ng/ml

260

17%

1.36

0.95

1.95

0.088

Post Initial TACE AFP ≥ 400 ng/ml

177

13%

2.41

1.49

3.90

<0.001